NCT01964274

Brief Summary

In this prospective, multicenter observational study the investigators capture the perioperative course of peripheral cholinesterase activity. The focus is the perioperative inflammation causing postoperative delirium. Therefore we measure the activity of Acetylcholine-Esterase and Butyrylcholine-Esterase in whole blood of adults in the perioperative context. Early postoperative delirium will be detected by Nu-DESC in the Recovery Room or the Postanaesthesia-Care-Unit. The course of the peripheral cholinesterase activity will be compared with the incidence of postoperative delirium and other clinical dysfunctions. We follow up the patients for up to five years regarding Delirum, comorbidities and mortality data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
815

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Typical duration for all trials

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 17, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

August 21, 2019

Status Verified

August 1, 2019

Enrollment Period

2.8 years

First QC Date

October 15, 2013

Last Update Submit

August 19, 2019

Conditions

Keywords

Nursing Delirium Screening Scale,Acetylcholinesterase Activity

Outcome Measures

Primary Outcomes (1)

  • Postoperative Delirium

    Postoperative Delirium (measured by Nursing Delirium Screening Scale)

    Participants will be followed in the sample period, an exspected average of three days

Secondary Outcomes (11)

  • Organ Dysfunctions

    Participants will be followed in the sample period, an exspected average of three days

  • Concomitant medication

    Participants will be followed in the three postoperative days sample period

  • Postoperative Pain

    Participants will be followed in the three postoperative days sample period

  • Duration of Intensive Care Unit Stay

    Participants will be followed in the sample period, an exspected average of seven days

  • Duration of Hospital Stay

    Participants will be followed in the sample period, an exspected average of four weeks

  • +6 more secondary outcomes

Study Arms (1)

Surgical patients

Adult male and female patients undergoing surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult, elective surgery patients of both gender

You may qualify if:

  • Male and female patients with age 18 years and above scheduled for surgery with planned stay in Recovery Room or Postanesthesia-Care-Unit
  • Offered patient information and written informed consent
  • In-hospital stay for at least 24 hours

You may not qualify if:

  • Patients with known pseudocholinesterase deficiency
  • Participation in prospective intervention studies during the study period
  • Analphabetism
  • Unability of German and English language use
  • Anacusis or Hypoacusis with hearing aid device, Amaurosis
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • Coworker of the clinic (study center)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin

Berlin, 13353, Germany

Location

Department of Anesthesia, Klinik für MIC

Berlin, 14129, Germany

Location

Clinic for Anaesthesiology, Intensive Care Medicine, Palliative Medicine and Pain Medicine, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil

Bochum, 44789, Germany

Location

Department of Anesthesiology, Universitätsklinikum Heidelberg

Heidelberg, 69120, Germany

Location

Department of Anesthesiology, Klinikum Großhadern of the Ludwig Maximilians University of Munich

München, 81377, Germany

Location

Department of Anesthesiology, Universitätsklinikum Regensburg

Regensburg, 93053, Germany

Location

Department of Anesthesiology, Universitätsklinikum Ulm

Ulm, 89081, Germany

Location

Department of anesthesiology and intensive care medicine

Wetzlar, 35578, Germany

Location

Department of Anaesthesia and Critical Care, Universitätsklinikum Würzburg

Würzburg, 97080, Germany

Location

Related Publications (2)

  • Muller A, Olbert M, Heymann A, Zahn PK, Plaschke K, von Dossow V, Bitzinger D, Barth E, Meister M, Kranke P, Herrmann C, Wernecke KD, Spies CD. Relevance of peripheral cholinesterase activity on postoperative delirium in adult surgical patients (CESARO): A prospective observational cohort study. Eur J Anaesthesiol. 2019 Feb;36(2):114-122. doi: 10.1097/EJA.0000000000000888.

  • Michels B, Holzamer A, Graf BM, Bredthauer A, Petermichl W, Muller A, Zausig YA, Bitzinger DI. Butyrylcholinesterase as a perioperative complication marker in patients after transcatheter aortic valve implantation: a prospective observational study. BMJ Open. 2021 Jul 6;11(7):e042857. doi: 10.1136/bmjopen-2020-042857.

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Claudia Spies, MD

    Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite - Universitätsmedizin Berlin, Germany

Study Record Dates

First Submitted

October 15, 2013

First Posted

October 17, 2013

Study Start

October 1, 2013

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

August 21, 2019

Record last verified: 2019-08

Locations